What is the importance of identifying and addressing microvascular disease, and specifically microvascular obstruction in heart attack patients?
What is coronary microvasculature?
What is a microvascular obstruction (MVO)?
How is MVO measured and detected today?
What happens if MVO is not detected or treated?
What is the importance of identifying and addressing microvascular disease, and specifically microvascular obstruction in heart attack patients?
What is coronary microvasculature?
What is a microvascular obstruction (MVO)?
How is MVO measured and detected today?
What happens if MVO is not detected or treated?
The CorFlow Controlled Flow Infusion (CoFI) System
- ACCURATELY detect MVO vs gold standard CMRI in STEMI patients*.
- RAPIDLY deliver microvascular diagnostic information in minutes.
- SEAMLESSLY fit into the PCI workflow, using the existing guide catheter and wire access.
- SAFELY deliver pharmaceutical or other therapeutic agent directly into the vasculature in a timely, controlled, safe infusion*.
The CoFI System has been created by physicians for physicians, to change the paradigm of diagnosis and treatment of heart attack patients. It is a singular innovation, years in the making — rooted firmly in sound research, from benchtop science to clinical use in humans. The development goals include improving cardiac patient outcomes, expanding physician treatment capabilities, and reducing inequalities to receive state-of-the-art care.
The CorFlow Controlled Flow Infusion (CoFI™) System
- ACCURATELY detect MVO vs gold standard CMRI in STEMI patients*.
- RAPIDLY deliver microvascular diagnostic information in minutes.
- SEAMLESSLY fit into the PCI workflow, using the existing guide catheter and wire access.
- SAFELY deliver pharmaceutical or other therapeutic agent directly into the vasculature in a timely, controlled, safe infusion*.
The CoFI System has been created by physicians for physicians, to change the paradigm of diagnosis and treatment of heart attack patients. It is a singular innovation, years in the making — rooted firmly in sound research, from benchtop science to clinical use in humans. The development goals include improving cardiac patient outcomes, expanding physician treatment capabilities, and reducing inequalities to receive state-of-the-art care.
Our Vision ?
To be the leader in diagnostic and therapeutic solutions for restoring healthy microvascular blood flow anywhere in the human body where a critical need exists.
Our Vision ?
To be the leader in diagnostic and therapeutic solutions for restoring healthy microvascular blood flow anywhere in the human body where a critical need exists.
News
Our Office
- +41 41 399 18 00
- CorFlow Therapeutics AG Neuhofstrasse 3d 6340 Baar, Switzerland
- contact@corflow.ch
The CoFI-System is not approved in the United States of America. It is an investigational device limited by federal law to investigational use and is not available for commercial distribution.
VAT:CHE 320.873.257 MWST
© 2024 Corflow. All Rights Reserved.